Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease

scientific article

Immune markers and differential signaling networks in ulcerative colitis and Crohn's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/IBD.22957
P932PMC publication ID3407828
P698PubMed publication ID22467146
P5875ResearchGate publication ID223979860

P2093author name stringRong Rong
Steve K Landas
George P Christophi
Paul T Massa
Philip G Holtzapple
P2860cites workGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseQ22251069
Genomic views of STAT function in CD4+ T helper cell differentiationQ24628039
Review of the activation of TGF-beta in immunityQ24635194
Genome-wide association identifies multiple ulcerative colitis susceptibility lociQ27865246
Nox enzymes and oxidative stress in the immunopathology of the gastrointestinal tractQ28282472
ADAM8: a new therapeutic target for asthmaQ28590394
Protein tyrosine phosphatases in the JAK/STAT pathwayQ28646447
The regulation of IL-10 production by immune cellsQ29615479
Inflammatory bowel diseaseQ29615500
Inflammatory bowel diseaseQ29616286
Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritisQ30434426
Translating tumor biology into personalized treatment planning: analytical performance characteristics of the Oncotype DX Colon Cancer AssayQ30497815
Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samplesQ30974811
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.Q33340603
Validation of putative reference genes for normalization of Q-RT-PCR data from paraffin-embedded lymphoid tissueQ33513066
Gene expression in formalin-fixed paraffin-embedded lymph nodesQ33613369
SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients.Q33904273
Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.Q38415968
Value of mucosal assessment and biomarkers in inflammatory bowel diseaseQ39866439
Arginase-1-expressing macrophages are dispensable for resistance to infection with the gastrointestinal helminth Trichuris muris.Q40409458
Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases.Q40453982
Down-regulation of TFF expression in gastrointestinal cell lines by cytokines and nuclear factorsQ40701561
Free radical-producing myeloid-derived regulatory cells: potent activators and suppressors of lung inflammation and airway hyperresponsivenessQ41557347
Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel diseaseQ41844866
Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.Q42840078
Role of cytokines in inflammatory bowel diseaseQ43065113
Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitisQ43628018
Distinct promoters regulate tissue-specific and differential expression of kallikrein 6 in CNS demyelinating diseaseQ45177746
DNA methylation regulates constitutive expression of Stat6 regulatory genes SOCS-1 and SHP-1 in colon cancer cells.Q45955702
NADPH oxidases contribute to autophagy regulation.Q45956086
Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosaQ47787205
Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel diseaseQ47787267
Increased expression of CCL20 in human inflammatory bowel diseaseQ48008663
Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells.Q53286695
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatment.Q54387452
The −A2518G Polymorphism of Monocyte Chemoattractant Protein-1 Is Associated With Crohn's DiseaseQ60023210
Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel diseaseQ74593708
Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1Q77124651
Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel diseaseQ77626816
Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in miceQ80994922
Inverse regulation of inducible nitric oxide synthase (iNOS) and arginase I by the protein tyrosine phosphatase SHP-1 in CNS gliaQ82976155
Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.Q33905233
Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel diseaseQ33964919
Cellular and molecular basis for the regulation of inflammation by TGF-betaQ34028060
Novel genetic markers in inflammatory bowel diseaseQ34233119
Mucins in the gastrointestinal tract in health and diseaseQ34386379
Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.Q34574880
Effect of α4β7 blockade on intestinal lymphocyte subsets and lymphoid tissue developmentQ34690080
Interleukin-1beta converting enzyme (caspase-1) in intestinal inflammationQ34727085
Intestinal trefoil factor confers colonic epithelial resistance to apoptosisQ34978197
STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunctionQ35061825
Diagnostic Problems and Advances in Inflammatory Bowel DiseaseQ35105993
Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel diseaseQ35621619
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's diseaseQ36370178
GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factorsQ36391825
Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?Q36778853
SOCS proteins, cytokine signalling and immune regulationQ36831668
Inflammation-mediated cytosine damage: a mechanistic link between inflammation and the epigenetic alterations in human cancersQ36851776
Role of arginine metabolism in immunity and immunopathologyQ37034571
Mechanisms of SHP-1 P2 promoter regulation in hematopoietic cells and its silencing in HTLV-1-transformed T cellsQ37062143
NF-kappaB in inflammatory bowel diseaseQ37163422
High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBDQ37286157
Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotypeQ37301528
GWA studies: rewriting the story of IBD.Q37393352
T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human diseaseQ37416284
Potential role of Th17 cells in the pathogenesis of inflammatory bowel diseaseQ37468451
Increased serum levels of L-arginine in ulcerative colitis and correlation with disease severityQ37483190
Diagnostic standards in the pathology of inflammatory bowel diseaseQ37629484
Disease-associated functions of IL-33: the new kid in the IL-1 familyQ37676926
Future biologic targets for IBD: potentials and pitfallsQ37687874
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?Q37762230
Anti-adhesion molecule therapy for inflammatory bowel diseaseQ37823325
SHP-1 in cell-cycle regulationQ37835343
Genetics of ulcerative colitisQ37841401
Regulation of the DNA methyltransferase by the Ras-AP-1 signaling pathwayQ38299575
P433issue12
P921main subjectCrohn's diseaseQ1472
ulcerative colitisQ1477
P304page(s)2342-2356
P577publication date2012-03-29
P1433published inInflammatory Bowel DiseasesQ15749161
P1476titleImmune markers and differential signaling networks in ulcerative colitis and Crohn's disease
P478volume18

Reverse relations

cites work (P2860)
Q38694522Anti-inflammatory Effects of Fungal Metabolites in Mouse Intestine as Revealed by In vitro Models
Q47292177Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis
Q98227507Assessment of Systemic Genetic Damage in Pediatric Inflammatory Bowel Disease
Q44091952Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease
Q93074396Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions
Q37238312CD14+CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis.
Q33864128CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo
Q35860292Computational Prediction and Validation of BAHD1 as a Novel Molecule for Ulcerative Colitis
Q38286034Down the line from genome-wide association studies in inflammatory bowel disease: the resulting clinical benefits and the outlook for the future
Q53539411Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis.
Q35405853Effect of Infliximab in oxidised serum albumin levels during experimental colitis
Q34467240Effects of baicalin in CD4 + CD29 + T cell subsets of ulcerative colitis patients
Q36923640Emerging neuropeptide targets in inflammation: NPY and VIP
Q35067528Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung
Q38880724Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
Q38224879Experimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology.
Q37192429Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis
Q37347795Gene and Network Analysis of Common Variants Reveals Novel Associations in Multiple Complex Diseases
Q33723775Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis
Q29417001Genome-wide diet-gene interaction analyses for risk of colorectal cancer
Q33755171Growth Hormone Resistance-Special Focus on Inflammatory Bowel Disease.
Q41185159High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
Q35075300High-throughput multi-analyte Luminex profiling implicates eotaxin-1 in ulcerative colitis
Q37672624Identification of Candidate Genes Related to Inflammatory Bowel Disease Using Minimum Redundancy Maximum Relevance, Incremental Feature Selection, and the Shortest-Path Approach.
Q51051024Identification of inflammatory bowel disease-related proteins using a reverse k-nearest neighbor search.
Q34962856Immunohistochemical analysis of retinoblastoma and β-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis
Q39220077Immunological profiling of patients with ulcerative colitis leads to identification of two inflammatory conditions and CD1a as a disease marker
Q43700132Increased IL-17A/IL-17F expression ratio represents the key mucosal T helper/regulatory cell-related gene signature paralleling disease activity in ulcerative colitis
Q64112334Increased risk of chronic fatigue syndrome in patients with inflammatory bowel disease: a population-based retrospective cohort study
Q38797790Indigo Naturalis Ameliorates Oxazolone-Induced Dermatitis but Aggravates Colitis by Changing the Composition of Gut Microflora
Q47749878Integrated strategy of differentially expressed genes associated with ulcerative colitis
Q38117175Investigational cytokine-targeted therapies for ulcerative colitis.
Q35151385Isolation and optimization for affinity and biophysical characteristics of anti-CCL17 antibodies from the VH1-69 germline gene
Q50042190MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1.
Q50952715Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
Q49952999Monoglyceride lipase gene knockout in mice leads to increased incidence of lung adenocarcinoma
Q57110341Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease
Q37589114NADPH oxidase in brain injury and neurodegenerative disorders
Q54200104No association between the SOCS-1 -1478CA/del polymorphism and ulcerative colitis in Turkish subjects.
Q50635849Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Q59133604Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease
Q26747744Rectal budesonide and mesalamine formulations in active ulcerative proctosigmoiditis: efficacy, tolerance, and treatment approach
Q35775371Reduced incidence of Crohn's disease in systemic sclerosis: a nationwide population study.
Q47146914Regulation and Sensing of Inflammasomes and Their Impact on Intestinal Health
Q33857794S1pping fire: Sphingosine-1-phosphate signaling as an emerging target in inflammatory bowel disease and colitis-associated cancer
Q36708344Sphingosine-1-phosphate in inflammatory bowel disease and colitis-associated colon cancer: the fat's in the fire
Q30659867Systematically Prioritizing Functional Differentially Methylated Regions (fDMRs) by Integrating Multi-omics Data in Colorectal Cancer
Q90360008Taraxacum officinale extract ameliorates dextran sodium sulphate-induced colitis by regulating fatty acid degradation and microbial dysbiosis
Q87288268The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications
Q26829387The regulation of inflammation by interferons and their STATs
Q38191582Therapy with stem cells in inflammatory bowel disease
Q44696806Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
Q33592962Transcriptional and Molecular Pathways Activated in Mesenteric Adipose Tissue and Intestinal Mucosa of Crohn's Disease Patients.